Skip to content

Treatment of Free-Flowing Tuberculous Effusions with Double Lumen Central Venous Catheterization Drainage and Intracavitary Urokinase

Treatment of Free-Flowing Tuberculous Effusions with Double Lumen Central Venous Catheterization Drainage and Intracavitary Urokinase

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002197
Enrollment
Unknown
Registered
2012-05-11
Start date
2011-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Free-Flowing Tuberculous Effusions

Interventions

one lumen central venous catheterization placed
urokinase instillation
Double lumen tube group:standard anti-TB medications
double lumen central venous catheterization placed
urokinase instillation Intervention
control group:standard anti-TB medications in addition to therapeutic thoracentesis
Single lumen tube group:standard anti-TB medications

Sponsors

Institute of Surgery Research, Daping Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. non encapsulated tuberculous pleurisy; 2. agree to participate in clinical trials; 3. age from12 to 80 years old.

Exclusion criteria

Exclusion criteria: Absolute contraindication: 1. Any trauma,surgery, or major hemorrhage within 48 hrs; 2. Bronchopleural fistula; 3. History of allergic reaction to the drug. Relative contraindication or precaution: 1. Coagulation abnormality(or therapeutic anticoagulation); 2. Invasive thoracic or abdominalsurgery in the previous 2 wks; 3. History of cranial hemorrhage; 4. Surgery or trauma to the head inthe previous 2 wks.

Design outcomes

Primary

MeasureTime frame
occurrence of residual pleural thickening;The total effusion volumes remove;

Countries

China

Contacts

Public ContactCao Guoqiang
cgq1963@163.com+86 023 68757781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026